| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Coronary Artery Disease | 27 | 2019 | 2570 | 3.61 | Why? |
| Coronary Angiography | 22 | 2019 | 2275 | 2.67 | Why? |
| Computed Tomography Angiography | 12 | 2019 | 2153 | 2.19 | Why? |
| Sarcoidosis | 6 | 2019 | 271 | 2.00 | Why? |
| Vascular Calcification | 9 | 2019 | 396 | 1.49 | Why? |
| Coronary Vessels | 10 | 2019 | 914 | 1.44 | Why? |
| Cardiomyopathies | 7 | 2019 | 997 | 1.36 | Why? |
| Plaque, Atherosclerotic | 4 | 2019 | 423 | 1.27 | Why? |
| Chest Pain | 4 | 2019 | 578 | 1.26 | Why? |
| Myocardial Infarction | 5 | 2019 | 3361 | 0.99 | Why? |
| Endocarditis | 2 | 2018 | 368 | 0.95 | Why? |
| Myocardial Perfusion Imaging | 5 | 2019 | 218 | 0.90 | Why? |
| Cardiac Imaging Techniques | 4 | 2020 | 357 | 0.86 | Why? |
| Calcium | 5 | 2019 | 708 | 0.85 | Why? |
| Fractional Flow Reserve, Myocardial | 4 | 2019 | 173 | 0.82 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2018 | 1510 | 0.81 | Why? |
| Multimodal Imaging | 3 | 2020 | 534 | 0.79 | Why? |
| Positron-Emission Tomography | 10 | 2019 | 802 | 0.76 | Why? |
| Fluorodeoxyglucose F18 | 5 | 2019 | 1153 | 0.74 | Why? |
| Cocaine | 1 | 2018 | 73 | 0.71 | Why? |
| Diabetic Angiopathies | 1 | 2019 | 146 | 0.68 | Why? |
| Pulmonary Valve | 1 | 2017 | 31 | 0.67 | Why? |
| Marijuana Use | 1 | 2018 | 89 | 0.66 | Why? |
| Marijuana Abuse | 1 | 2018 | 111 | 0.66 | Why? |
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 279 | 0.66 | Why? |
| Mitral Valve | 2 | 2018 | 342 | 0.65 | Why? |
| Cardiovascular Agents | 3 | 2017 | 663 | 0.65 | Why? |
| Myocardial Ischemia | 3 | 2018 | 781 | 0.65 | Why? |
| Hyperlipoproteinemia Type II | 1 | 2018 | 123 | 0.64 | Why? |
| Tricuspid Valve | 1 | 2017 | 91 | 0.63 | Why? |
| Coronary Stenosis | 2 | 2017 | 273 | 0.63 | Why? |
| Coronary Circulation | 4 | 2019 | 188 | 0.62 | Why? |
| Risk Reduction Behavior | 3 | 2018 | 946 | 0.61 | Why? |
| Coronary Vessel Anomalies | 1 | 2017 | 87 | 0.61 | Why? |
| Heart Diseases | 4 | 2020 | 3503 | 0.60 | Why? |
| Eligibility Determination | 1 | 2017 | 255 | 0.59 | Why? |
| Heart Valve Prosthesis | 2 | 2018 | 533 | 0.59 | Why? |
| Tomography, X-Ray Computed | 10 | 2020 | 25144 | 0.56 | Why? |
| Abscess | 1 | 2017 | 234 | 0.56 | Why? |
| Coronary Disease | 2 | 2017 | 645 | 0.52 | Why? |
| Aspergillosis | 1 | 2017 | 264 | 0.52 | Why? |
| Radiopharmaceuticals | 2 | 2019 | 763 | 0.51 | Why? |
| Predictive Value of Tests | 19 | 2021 | 9537 | 0.50 | Why? |
| Aortic Valve | 2 | 2017 | 664 | 0.49 | Why? |
| Candidiasis | 1 | 2017 | 334 | 0.49 | Why? |
| Transcatheter Aortic Valve Replacement | 2 | 2018 | 839 | 0.48 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.47 | Why? |
| Metabolic Syndrome | 2 | 2017 | 810 | 0.47 | Why? |
| Cardiovascular Diseases | 14 | 2021 | 11497 | 0.46 | Why? |
| Appointments and Schedules | 1 | 2020 | 1204 | 0.46 | Why? |
| Positron Emission Tomography Computed Tomography | 3 | 2018 | 1458 | 0.45 | Why? |
| Aortic Valve Stenosis | 2 | 2019 | 741 | 0.45 | Why? |
| Registries | 8 | 2019 | 12327 | 0.43 | Why? |
| Atherosclerosis | 5 | 2019 | 768 | 0.42 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.41 | Why? |
| Drug Costs | 3 | 2018 | 313 | 0.39 | Why? |
| Heart Valves | 2 | 2018 | 52 | 0.37 | Why? |
| Diagnostic Techniques, Cardiovascular | 2 | 2020 | 144 | 0.34 | Why? |
| Health Expenditures | 5 | 2018 | 904 | 0.34 | Why? |
| Mucormycosis | 1 | 2017 | 832 | 0.34 | Why? |
| Heart | 3 | 2021 | 1791 | 0.32 | Why? |
| Prognosis | 17 | 2019 | 32490 | 0.31 | Why? |
| Hypolipidemic Agents | 2 | 2018 | 208 | 0.30 | Why? |
| Boston | 3 | 2017 | 929 | 0.29 | Why? |
| Magnetic Resonance Imaging, Cine | 3 | 2020 | 669 | 0.29 | Why? |
| Microcirculation | 3 | 2019 | 447 | 0.29 | Why? |
| Humans | 86 | 2021 | 930598 | 0.28 | Why? |
| Decision Making | 1 | 2019 | 3132 | 0.28 | Why? |
| Diabetes Mellitus | 5 | 2019 | 8207 | 0.28 | Why? |
| Heart Failure | 3 | 2021 | 6638 | 0.27 | Why? |
| Chi-Square Distribution | 2 | 2017 | 961 | 0.26 | Why? |
| Lipids | 3 | 2018 | 1079 | 0.25 | Why? |
| Healthy Lifestyle | 2 | 2018 | 447 | 0.25 | Why? |
| Echocardiography, Doppler, Color | 3 | 2018 | 114 | 0.25 | Why? |
| Risk Factors | 24 | 2020 | 71621 | 0.24 | Why? |
| Echocardiography, Transesophageal | 4 | 2020 | 447 | 0.23 | Why? |
| Health Care Costs | 4 | 2017 | 1007 | 0.23 | Why? |
| Safety Management | 2 | 2020 | 1093 | 0.23 | Why? |
| Risk Assessment | 16 | 2020 | 25439 | 0.23 | Why? |
| Radiation Dosage | 2 | 2017 | 585 | 0.23 | Why? |
| North America | 3 | 2020 | 1400 | 0.22 | Why? |
| Protective Factors | 5 | 2018 | 1720 | 0.22 | Why? |
| Diagnostic Imaging | 3 | 2020 | 1044 | 0.22 | Why? |
| Dyslipidemias | 2 | 2018 | 791 | 0.22 | Why? |
| Primary Prevention | 2 | 2018 | 778 | 0.22 | Why? |
| Defibrillators, Implantable | 2 | 2018 | 624 | 0.22 | Why? |
| Exercise Test | 3 | 2017 | 911 | 0.21 | Why? |
| Ventricular Function, Left | 3 | 2019 | 1555 | 0.21 | Why? |
| Health Services Misuse | 1 | 2021 | 81 | 0.21 | Why? |
| Practice Guidelines as Topic | 3 | 2019 | 15421 | 0.20 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 9706 | 0.20 | Why? |
| Time Factors | 15 | 2019 | 31397 | 0.20 | Why? |
| Funnel Chest | 1 | 2018 | 11 | 0.19 | Why? |
| Thrombosis | 2 | 2018 | 7504 | 0.19 | Why? |
| Medically Uninsured | 2 | 2018 | 237 | 0.19 | Why? |
| Fistula | 1 | 2018 | 34 | 0.19 | Why? |
| Hematopoiesis | 1 | 2019 | 168 | 0.19 | Why? |
| Heart Transplantation | 2 | 2019 | 1293 | 0.19 | Why? |
| Cardiology | 3 | 2020 | 2873 | 0.19 | Why? |
| Heart Failure, Diastolic | 1 | 2018 | 21 | 0.18 | Why? |
| American Heart Association | 2 | 2017 | 347 | 0.18 | Why? |
| United States | 23 | 2021 | 46150 | 0.18 | Why? |
| Ranolazine | 1 | 2017 | 17 | 0.17 | Why? |
| Middle Aged | 34 | 2019 | 270681 | 0.17 | Why? |
| Societies, Medical | 6 | 2020 | 6907 | 0.17 | Why? |
| Constriction, Pathologic | 1 | 2018 | 212 | 0.17 | Why? |
| Obesity | 2 | 2017 | 7388 | 0.16 | Why? |
| Cardiovascular Surgical Procedures | 1 | 2020 | 281 | 0.16 | Why? |
| Hematopoietic Stem Cells | 1 | 2019 | 321 | 0.16 | Why? |
| Tobacco | 1 | 2018 | 274 | 0.16 | Why? |
| Electrophysiologic Techniques, Cardiac | 1 | 2020 | 396 | 0.16 | Why? |
| Debridement | 1 | 2017 | 172 | 0.16 | Why? |
| Male | 37 | 2020 | 367725 | 0.15 | Why? |
| Heart Function Tests | 1 | 2016 | 101 | 0.15 | Why? |
| Nonlinear Dynamics | 1 | 2017 | 177 | 0.15 | Why? |
| Tomography, Spiral Computed | 1 | 2016 | 109 | 0.15 | Why? |
| Adult | 22 | 2019 | 244371 | 0.15 | Why? |
| Ventricular Remodeling | 1 | 2019 | 349 | 0.15 | Why? |
| Calcinosis | 1 | 2018 | 240 | 0.15 | Why? |
| Age of Onset | 1 | 2017 | 557 | 0.15 | Why? |
| Bioprosthesis | 1 | 2017 | 126 | 0.15 | Why? |
| Patient Protection and Affordable Care Act | 1 | 2017 | 164 | 0.15 | Why? |
| Syncope | 1 | 2018 | 238 | 0.15 | Why? |
| Prosthesis Failure | 1 | 2017 | 195 | 0.14 | Why? |
| Female | 37 | 2020 | 380317 | 0.14 | Why? |
| Treatment Outcome | 10 | 2019 | 51732 | 0.14 | Why? |
| Anticholesteremic Agents | 1 | 2017 | 186 | 0.14 | Why? |
| Medical Overuse | 1 | 2017 | 146 | 0.14 | Why? |
| Device Removal | 1 | 2017 | 221 | 0.14 | Why? |
| Stroke | 4 | 2018 | 8839 | 0.14 | Why? |
| Stroke Volume | 3 | 2019 | 2153 | 0.14 | Why? |
| Heart Valve Prosthesis Implantation | 2 | 2018 | 552 | 0.13 | Why? |
| Ischemic Attack, Transient | 1 | 2018 | 439 | 0.13 | Why? |
| Cigarette Smoking | 1 | 2018 | 337 | 0.13 | Why? |
| Warfarin | 1 | 2018 | 402 | 0.13 | Why? |
| Mitral Valve Insufficiency | 1 | 2018 | 302 | 0.13 | Why? |
| Biopsy | 3 | 2018 | 2811 | 0.13 | Why? |
| Atrial Fibrillation | 2 | 2018 | 2320 | 0.13 | Why? |
| Radiation Exposure | 1 | 2015 | 161 | 0.13 | Why? |
| Severity of Illness Index | 5 | 2019 | 48226 | 0.13 | Why? |
| Odds Ratio | 4 | 2018 | 5861 | 0.13 | Why? |
| Adrenergic beta-Antagonists | 1 | 2017 | 465 | 0.13 | Why? |
| Cardiology Service, Hospital | 1 | 2020 | 602 | 0.13 | Why? |
| Aged | 26 | 2019 | 215776 | 0.13 | Why? |
| Death, Sudden, Cardiac | 1 | 2018 | 522 | 0.13 | Why? |
| Magnetic Resonance Imaging | 3 | 2019 | 6551 | 0.12 | Why? |
| Decision Support Techniques | 2 | 2017 | 903 | 0.12 | Why? |
| Pacemaker, Artificial | 1 | 2017 | 431 | 0.12 | Why? |
| Retrospective Studies | 13 | 2019 | 105322 | 0.12 | Why? |
| Young Adult | 11 | 2019 | 93724 | 0.12 | Why? |
| Myocarditis | 2 | 2019 | 2731 | 0.12 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.12 | Why? |
| Quality Indicators, Health Care | 1 | 2017 | 580 | 0.11 | Why? |
| Preventive Health Services | 1 | 2017 | 501 | 0.11 | Why? |
| Vaping | 1 | 2018 | 436 | 0.11 | Why? |
| Patient Reported Outcome Measures | 1 | 2017 | 912 | 0.11 | Why? |
| Prevalence | 6 | 2019 | 25773 | 0.11 | Why? |
| Consensus | 4 | 2020 | 6345 | 0.11 | Why? |
| Ventricular Dysfunction, Right | 1 | 2018 | 639 | 0.11 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.11 | Why? |
| Patient Safety | 3 | 2020 | 4885 | 0.11 | Why? |
| Proportional Hazards Models | 3 | 2019 | 6543 | 0.10 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.10 | Why? |
| Fatal Outcome | 2 | 2017 | 3438 | 0.10 | Why? |
| Policy Making | 1 | 2017 | 829 | 0.10 | Why? |
| Athletes | 1 | 2018 | 1047 | 0.10 | Why? |
| Autopsy | 2 | 2018 | 3495 | 0.10 | Why? |
| Body Mass Index | 3 | 2018 | 4306 | 0.10 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.10 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.10 | Why? |
| Occupational Health | 3 | 2020 | 3965 | 0.10 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.10 | Why? |
| Social Class | 1 | 2017 | 1360 | 0.10 | Why? |
| Health Surveys | 2 | 2017 | 2841 | 0.09 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.09 | Why? |
| Area Under Curve | 1 | 2016 | 2564 | 0.09 | Why? |
| Quality of Health Care | 2 | 2017 | 1948 | 0.09 | Why? |
| Patient-Centered Care | 1 | 2017 | 860 | 0.09 | Why? |
| Echocardiography | 3 | 2018 | 3661 | 0.09 | Why? |
| Cohort Studies | 4 | 2019 | 36005 | 0.09 | Why? |
| Patient Compliance | 1 | 2017 | 1468 | 0.08 | Why? |
| Physician-Patient Relations | 1 | 2017 | 1266 | 0.08 | Why? |
| Antifungal Agents | 1 | 2017 | 1828 | 0.08 | Why? |
| Risk Management | 1 | 2014 | 1044 | 0.08 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.08 | Why? |
| Poverty | 1 | 2017 | 2302 | 0.07 | Why? |
| Social Determinants of Health | 1 | 2017 | 1757 | 0.07 | Why? |
| Influenza Vaccines | 1 | 2021 | 2941 | 0.07 | Why? |
| Academic Medical Centers | 1 | 2017 | 3088 | 0.07 | Why? |
| Cost Savings | 2 | 2017 | 296 | 0.07 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Models, Economic | 2 | 2017 | 316 | 0.07 | Why? |
| Electronic Health Records | 1 | 2017 | 3492 | 0.07 | Why? |
| ROC Curve | 1 | 2016 | 6024 | 0.07 | Why? |
| Clinical Decision-Making | 4 | 2018 | 3755 | 0.07 | Why? |
| Electrocardiography | 2 | 2017 | 3957 | 0.06 | Why? |
| Health Resources | 1 | 2017 | 2592 | 0.06 | Why? |
| Health Care Surveys | 3 | 2018 | 2942 | 0.06 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.06 | Why? |
| Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.06 | Why? |
| Aged, 80 and over | 12 | 2019 | 88759 | 0.06 | Why? |
| Aging | 1 | 2019 | 3581 | 0.06 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2020 | 5164 | 0.06 | Why? |
| Patient Acceptance of Health Care | 1 | 2021 | 5002 | 0.06 | Why? |
| Workplace | 1 | 2014 | 2075 | 0.05 | Why? |
| Algorithms | 2 | 2019 | 7346 | 0.05 | Why? |
| Age Factors | 2 | 2019 | 21039 | 0.05 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Health Promotion | 1 | 2014 | 2020 | 0.05 | Why? |
| Acute Coronary Syndrome | 1 | 2014 | 2107 | 0.05 | Why? |
| Health Status Disparities | 1 | 2017 | 4072 | 0.05 | Why? |
| Gadolinium DTPA | 1 | 2019 | 45 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.05 | Why? |
| Communication | 1 | 2017 | 5206 | 0.05 | Why? |
| Mutation | 1 | 2019 | 12376 | 0.05 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 8811 | 0.05 | Why? |
| Longitudinal Studies | 3 | 2018 | 9893 | 0.05 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Hospital Charges | 1 | 2017 | 56 | 0.04 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.04 | Why? |
| Carotid Intima-Media Thickness | 1 | 2018 | 179 | 0.04 | Why? |
| Cost-Benefit Analysis | 2 | 2017 | 2259 | 0.04 | Why? |
| Sensitivity and Specificity | 2 | 2019 | 22971 | 0.04 | Why? |
| Health Policy | 1 | 2017 | 6242 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Nutrition Surveys | 1 | 2018 | 287 | 0.04 | Why? |
| Diastole | 1 | 2017 | 168 | 0.04 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.04 | Why? |
| Radionuclide Imaging | 1 | 2018 | 184 | 0.04 | Why? |
| Leadership | 2 | 2020 | 2241 | 0.04 | Why? |
| Blood Pressure | 2 | 2018 | 2198 | 0.04 | Why? |
| Hypercholesterolemia | 1 | 2017 | 175 | 0.04 | Why? |
| Tobacco Smoke Pollution | 1 | 2018 | 181 | 0.04 | Why? |
| Incidence | 4 | 2018 | 25622 | 0.04 | Why? |
| Internet | 1 | 2014 | 6204 | 0.04 | Why? |
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 98 | 0.04 | Why? |
| Tobacco Use | 1 | 2018 | 340 | 0.04 | Why? |
| Insurance, Health, Reimbursement | 1 | 2016 | 205 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.03 | Why? |
| Monte Carlo Method | 1 | 2017 | 577 | 0.03 | Why? |
| Hospital Costs | 1 | 2017 | 274 | 0.03 | Why? |
| Quality-Adjusted Life Years | 1 | 2017 | 511 | 0.03 | Why? |
| Cause of Death | 2 | 2019 | 4823 | 0.03 | Why? |
| Smoking | 2 | 2018 | 3358 | 0.03 | Why? |
| Stakeholder Participation | 1 | 2017 | 481 | 0.03 | Why? |
| Health Status | 2 | 2018 | 3259 | 0.03 | Why? |
| Evidence-Based Medicine | 2 | 2017 | 3228 | 0.03 | Why? |
| Cross-Over Studies | 1 | 2017 | 867 | 0.03 | Why? |
| Health Services | 1 | 2020 | 765 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Blood Glucose | 2 | 2018 | 3642 | 0.03 | Why? |
| Search Engine | 1 | 2020 | 628 | 0.03 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.03 | Why? |
| Emergency Service, Hospital | 2 | 2017 | 14232 | 0.03 | Why? |
| Contrast Media | 1 | 2019 | 1011 | 0.03 | Why? |
| PubMed | 1 | 2014 | 246 | 0.03 | Why? |
| Educational Status | 1 | 2018 | 1451 | 0.03 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.03 | Why? |
| Exercise Tolerance | 1 | 2017 | 634 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2019 | 11304 | 0.03 | Why? |
| Regression Analysis | 1 | 2019 | 2484 | 0.03 | Why? |
| Troponin | 1 | 2018 | 1058 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2017 | 1262 | 0.03 | Why? |
| Nuclear Medicine | 1 | 2018 | 585 | 0.03 | Why? |
| Adolescent | 5 | 2018 | 86841 | 0.03 | Why? |
| Ventricular Dysfunction, Left | 1 | 2018 | 993 | 0.02 | Why? |
| Socioeconomic Factors | 2 | 2018 | 8495 | 0.02 | Why? |
| Drug Prescriptions | 1 | 2018 | 1062 | 0.02 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.02 | Why? |
| Smoking Cessation | 1 | 2017 | 826 | 0.02 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.02 | Why? |
| Income | 1 | 2017 | 1564 | 0.02 | Why? |
| Bayes Theorem | 1 | 2017 | 3237 | 0.02 | Why? |
| Exercise | 2 | 2018 | 6771 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Alcohol Drinking | 1 | 2018 | 1663 | 0.02 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Arrhythmias, Cardiac | 1 | 2018 | 2510 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2017 | 3444 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Substance-Related Disorders | 1 | 2018 | 2038 | 0.02 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.02 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.01 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Healthcare Disparities | 1 | 2018 | 3893 | 0.01 | Why? |
| Disease Progression | 1 | 2019 | 13580 | 0.01 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.01 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.01 | Why? |
| Mental Health | 1 | 2017 | 15770 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |